Hifibio Therapeutics
Clinical trials sponsored by Hifibio Therapeutics, explained in plain language.
-
New drug combo tested for tough cancers
Disease control OngoingThis study tests an experimental drug called HFB200301, given alone or with another drug (tislelizumab), in adults with advanced solid tumors like stomach, kidney, or lung cancer. The goal is to find a safe dose and see how well people tolerate it. About 72 participants will take…
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New antibody combo shows promise in early cancer trial
Disease control OngoingThis study tests a new experimental drug, HFB200603, either alone or combined with another cancer drug (tislelizumab), in adults with advanced solid tumors like kidney, lung, skin, stomach, or colorectal cancer. The goal is to find safe doses and understand side effects. About 83…
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated May 19, 2026 11:47 UTC